Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bottomley, D"'
Autor:
Parikh S; Department of Clinical Oncology, St James's Institute of Oncology, St James's University Hospital, Leeds, UK., Murray L; Department of Clinical Oncology, St James's Institute of Oncology, St James's University Hospital, Leeds, UK., Kenning L; Departments of Clinical Oncology and Nuclear Medicine, Castle Hill Hospital, Cottingham, UK., Bottomley D; Department of Clinical Oncology, St James's Institute of Oncology, St James's University Hospital, Leeds, UK., Din O; Department of Clinical Oncology, Weston Park Hospital, Sheffield, UK., Dixit S; Departments of Clinical Oncology and Nuclear Medicine, Castle Hill Hospital, Cottingham, UK., Ferguson C; Department of Clinical Oncology, Weston Park Hospital, Sheffield, UK., Handforth C; Department of Clinical Oncology, Weston Park Hospital, Sheffield, UK., Joseph L; Department of Clinical Oncology, St James's Institute of Oncology, St James's University Hospital, Leeds, UK., Mokhtar D; Department of Clinical Oncology, Weston Park Hospital, Sheffield, UK., White L; Department of Clinical Oncology, St James's Institute of Oncology, St James's University Hospital, Leeds, UK., Wright G; Departments of Clinical Oncology and Nuclear Medicine, Castle Hill Hospital, Cottingham, UK., Henry AM; Department of Clinical Oncology, St James's Institute of Oncology, St James's University Hospital, Leeds, UK. Electronic address: a.henry@leeds.ac.uk.
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2018 Sep; Vol. 30 (9), pp. 548-555. Date of Electronic Publication: 2018 Jun 19.
Autor:
Parker C; Royal Marsden Hospital, Sutton, London, UK. Electronic address: chris.parker@rmh.nhs.uk., Finkelstein SE; Cancer Treatment Centers of America, Tulsa, OK, USA., Michalski JM; Washington University School of Medicine, St Louis, MO, USA., O'Sullivan JM; Center for Cancer Research and Cell Biology, Queen's University, Belfast, UK., Bruland Ø; Norwegian Radium Hospital, Oslo, Norway., Vogelzang NJ; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA., Coleman RE; University of Sheffield, Sheffield, South Yorkshire, UK., Nilsson S; Karolinska University Hospital, Stockholm, Sweden., Sartor O; Tulane Cancer Center, New Orleans, LA, USA., Li R; Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA., Seger MA; Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA., Bottomley D; St. James University Hospital, Leeds, Yorkshire, UK.
Publikováno v:
European urology [Eur Urol] 2016 Nov; Vol. 70 (5), pp. 875-883. Date of Electronic Publication: 2016 Jun 22.
Autor:
Hoskin P; Mount Vernon Cancer Centre, Northwood, Middlesex, UK. Electronic address: peterhoskin@nhs.net., Sartor O; Tulane Cancer Center, New Orleans, LA, USA., O'Sullivan JM; Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK., Johannessen DC; Ullevål University Hospital, Oslo, Norway., Helle SI; Haukeland University Hospital, Bergen, Norway., Logue J; Christie Hospital, Manchester, UK., Bottomley D; St James's University Hospital, Leeds, UK., Nilsson S; Karolinska University Hospital, Stockholm, Sweden., Vogelzang NJ; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA., Fang F; Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA., Wahba M; Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA., Aksnes AK; Algeta ASA (Bayer), Oslo, Norway., Parker C; The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2014 Nov; Vol. 15 (12), pp. 1397-406. Date of Electronic Publication: 2014 Oct 17.